Register for our webinar to learn about a study which aimed to evaluate disease stage-associated differences in receptor tyrosine kinase (RTK) signaling in A549 cells using pretreatment sera from cases of pathologically-confirmed lung adenocarcinoma at various stages of disease progression or control cases derived from a lung cancer screening study. This was accomplished as a means to explore the hypothesis that circulating concentrations of decoy receptors and/or ligands, as well as disease-specific ligand degradation all regulate RTK signaling in vivo.

Links:

https://event.on24.com/wcc/r/1427624/FF7E99E7C7DD84239BD8F5DCF2F2B313?partnerref=ContractLab

Download Attachments: